India's Astrazeneca Pharma gains 2% on nod to import breast cancer drug

Astrazeneca Pharma India

04/05/2023 10:14

** Shares of Astrazeneca Pharma India Ltd  ASTR.NS  rise as
much as 2.58% to 3244.70 rupees
    ** Drugmaker gets permission from the Indian drug regulator
to import its breast cancer drug, Trastuzumak deruxtecan, for
sale and distribution in India
    ** Trading volume is 7168 shares as of 2:34 p.m. IST, 1.5x
the 30-day avg - Refinitiv data
    


 (Reporting by Bharath Rajeswaran in Bengaluru)
 ((bharath.rajeswaran@thomsonreuters.com; +91 9769003463))